289 related articles for article (PubMed ID: 24013225)
1. Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo.
Zhou ZN; Sharma VP; Beaty BT; Roh-Johnson M; Peterson EA; Van Rooijen N; Kenny PA; Wiley HS; Condeelis JS; Segall JE
Oncogene; 2014 Jul; 33(29):3784-93. PubMed ID: 24013225
[TBL] [Abstract][Full Text] [Related]
2. Autocrine-derived epidermal growth factor receptor ligands contribute to recruitment of tumor-associated macrophage and growth of basal breast cancer cells in vivo.
Nickerson NK; Mill CP; Wu HJ; Riese DJ; Foley J
Oncol Res; 2013; 20(7):303-17. PubMed ID: 23879171
[TBL] [Abstract][Full Text] [Related]
3. Autocrine expression of the epidermal growth factor receptor ligand heparin-binding EGF-like growth factor in cervical cancer.
Schrevel M; Osse EM; Prins FA; Trimbos JBMZ; Fleuren GJ; Gorter A; Jordanova ES
Int J Oncol; 2017 Jun; 50(6):1947-1954. PubMed ID: 28498437
[TBL] [Abstract][Full Text] [Related]
4. Decreased autocrine EGFR signaling in metastatic breast cancer cells inhibits tumor growth in bone and mammary fat pad.
Nickerson NK; Mohammad KS; Gilmore JL; Crismore E; Bruzzaniti A; Guise TA; Foley J
PLoS One; 2012; 7(1):e30255. PubMed ID: 22276166
[TBL] [Abstract][Full Text] [Related]
5. Heparin-binding epidermal growth factor-like growth factor is a potent regulator of invasion activity in oral squamous cell carcinoma.
Ohnishi Y; Inoue H; Furukawa M; Kakudo K; Nozaki M
Oncol Rep; 2012 Apr; 27(4):954-8. PubMed ID: 22209887
[TBL] [Abstract][Full Text] [Related]
6. Role of G protein-coupled receptors (GPCR), matrix metalloproteinases 2 and 9 (MMP2 and MMP9), heparin-binding epidermal growth factor-like growth factor (hbEGF), epidermal growth factor receptor (EGFR), erbB2, and insulin-like growth factor 1 receptor (IGF-1R) in trenbolone acetate-stimulated bovine satellite cell proliferation.
Thornton KJ; Kamange-Sollo E; White ME; Dayton WR
J Anim Sci; 2015 Sep; 93(9):4291-301. PubMed ID: 26440329
[TBL] [Abstract][Full Text] [Related]
7. Autocrine CSF1R signaling mediates switching between invasion and proliferation downstream of TGFβ in claudin-low breast tumor cells.
Patsialou A; Wang Y; Pignatelli J; Chen X; Entenberg D; Oktay M; Condeelis JS
Oncogene; 2015 May; 34(21):2721-31. PubMed ID: 25088194
[TBL] [Abstract][Full Text] [Related]
8. Autocrine and juxtacrine effects of amphiregulin on the proliferative, invasive, and migratory properties of normal and neoplastic human mammary epithelial cells.
Willmarth NE; Ethier SP
J Biol Chem; 2006 Dec; 281(49):37728-37. PubMed ID: 17035230
[TBL] [Abstract][Full Text] [Related]
9. Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor.
Patsialou A; Wyckoff J; Wang Y; Goswami S; Stanley ER; Condeelis JS
Cancer Res; 2009 Dec; 69(24):9498-506. PubMed ID: 19934330
[TBL] [Abstract][Full Text] [Related]
10. EGFR ligands drive multipotential stromal cells to produce multiple growth factors and cytokines via early growth response-1.
Kerpedjieva SS; Kim DS; Barbeau DJ; Tamama K
Stem Cells Dev; 2012 Sep; 21(13):2541-51. PubMed ID: 22316125
[TBL] [Abstract][Full Text] [Related]
11. Invasive breast carcinoma cells from patients exhibit MenaINV- and macrophage-dependent transendothelial migration.
Pignatelli J; Goswami S; Jones JG; Rohan TE; Pieri E; Chen X; Adler E; Cox D; Maleki S; Bresnick A; Gertler FB; Condeelis JS; Oktay MH
Sci Signal; 2014 Nov; 7(353):ra112. PubMed ID: 25429076
[TBL] [Abstract][Full Text] [Related]
12. A novel neuregulin - jagged1 paracrine loop in breast cancer transendothelial migration.
Cabrera RM; Mao SPH; Surve CR; Condeelis JS; Segall JE
Breast Cancer Res; 2018 Apr; 20(1):24. PubMed ID: 29636067
[TBL] [Abstract][Full Text] [Related]
13. Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells.
Zhang X; Diaz MR; Yee D
Breast Cancer Res Treat; 2013 Jun; 139(2):351-60. PubMed ID: 23686416
[TBL] [Abstract][Full Text] [Related]
14. Testes-specific protease 50 promotes cell invasion and metastasis by increasing NF-kappaB-dependent matrix metalloproteinase-9 expression.
Song ZB; Ni JS; Wu P; Bao YL; Liu T; Li M; Fan C; Zhang WJ; Sun LG; Huang YX; Li YX
Cell Death Dis; 2015 Mar; 6(3):e1703. PubMed ID: 25811800
[TBL] [Abstract][Full Text] [Related]
15. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop.
Goswami S; Sahai E; Wyckoff JB; Cammer M; Cox D; Pixley FJ; Stanley ER; Segall JE; Condeelis JS
Cancer Res; 2005 Jun; 65(12):5278-83. PubMed ID: 15958574
[TBL] [Abstract][Full Text] [Related]
16. Human trophoblast survival at low oxygen concentrations requires metalloproteinase-mediated shedding of heparin-binding EGF-like growth factor.
Armant DR; Kilburn BA; Petkova A; Edwin SS; Duniec-Dmuchowski ZM; Edwards HJ; Romero R; Leach RE
Development; 2006 Feb; 133(4):751-9. PubMed ID: 16407398
[TBL] [Abstract][Full Text] [Related]
17. Heparin-binding epidermal growth factor-like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition.
Yagi H; Yotsumoto F; Miyamoto S
Mol Cancer Ther; 2008 Oct; 7(10):3441-51. PubMed ID: 18852147
[TBL] [Abstract][Full Text] [Related]
18. LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling.
Lue HW; Yang X; Wang R; Qian W; Xu RZ; Lyles R; Osunkoya AO; Zhou BP; Vessella RL; Zayzafoon M; Liu ZR; Zhau HE; Chung LW
PLoS One; 2011; 6(11):e27720. PubMed ID: 22110740
[TBL] [Abstract][Full Text] [Related]
19. Tunneling nanotubes, a novel mode of tumor cell-macrophage communication in tumor cell invasion.
Hanna SJ; McCoy-Simandle K; Leung E; Genna A; Condeelis J; Cox D
J Cell Sci; 2019 Feb; 132(3):. PubMed ID: 30659112
[TBL] [Abstract][Full Text] [Related]
20. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
[Next] [New Search]
